NARA Discovery
Article Details
← Back to Search Results
Journal Article

CCL21/CCR7 axis regulates VEGF-D m6A modification to drive lymphangiogenesis and lymphatic metastasis in gallbladder cancer

Zhenheng Wu; Xinran Cai; Lei Jiang; Bin Lin; Wei Pan; Shengzhe Lin; Yanling Chen; Haijie Hong
Human Cell · Vol. 39, Issue 8 · 2026

Abstract

Gallbladder cancer (GBC), the most common malignancy of the biliary tract, exhibits a high propensity for lymphatic system invasion. However, the mechanisms underlying lymphatic metastasis in GBC remain poorly understood. Here, we demonstrate that C–C motif chemokine ligand 21 (CCL21) is significantly upregulated in GBC and positively correlates with lymphatic vessel density and lymph node metastasis. Both in vivo and in vitro experiments confirm that CCL21/CCR7 axis promotes lymphangiogenesis and lymphatic metastasis in GBC. Mechanistically, CCL21/CCR7 modulates Vascular Endothelial Growth Factor-D (VEGF-D) mRNA N6-Methyladenosine (m 6 A) modification in an AlkB homolog 5 (ALKBH5)-dependent manner, thereby regulating VEGF-D protein expression. Site-directed mutagenesis experiments reveal that m 6 A modification sites in the coding sequence (CDS) region of VEGF-D mRNA are critical for VEGF-D protein regulation. Collectively, our findings highlight that CCL21/CCR7 regulates VEGF-D expression via m 6 A modification, driving lymphatic metastasis in GBC.

Bibliographic Information

JournalHuman Cell
PublisherSpringer
Publication Date2026-07-24
Publication Year2026
Volume39
Issue8
Document TypeJournal Article
eISSN1749-0774
DOI10.1007/s13577-026-01420-1

Access Information

NARA Access Coverage2002-01-01~Current
Journal Homepagehttps://www.springer.com/journal/13577
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.